Local administration of aspirin with β-tricalcium phosphate/poly-lactic-co-glycolic acid (β-TCP/PLGA) could enhance osteoporotic bone regeneration
- 149 Downloads
Composite materials β-tricalcium phosphate (β-TCP) and poly-lactic-co-glycolic acid (PLGA) have achieved stable bone regeneration without cell transplantation in previous studies. Recent research shows that aspirin (ASP) has great potential in promoting bone regeneration. The objective of the present study was to incorporate PLGA into β-TCP combined with a lower single-dose local administration of ASP to enhance its in vivo biodegradation and bone tissue growth. After the creation of a rodent critical-sized femoral metaphyseal bone defect, PLGA -modified β-TCP (TP) was prepared by mixing sieved granules of β-TCP and PLGA (50:50, v/v) for medical use, then TP with dripped 50 µg/0.1 ml and 100 µg/0.1 ml aspirin solution was implanted into the defect of OVX rats until death at 8 weeks. The defected area in distal femurs of rats was harvested for evaluation by histology, micro-CT, biomechanics and real time RT-PCR. The results of our study show that a single-dose local administration of ASP combined with the local usage of TP can increase the healing of defects in OVX rats. Single-dose local administration of aspirin can improve the transcription of genes involved in the regulation of bone formation and vascularization in the defect area, and inhibits osteoclast activity. Furthermore, treatments with a higher single-dose local administration of ASP and TP showed a stronger effect on accelerating the local bone formation than while using a lower dose of ASP. The results from our study demonstrate that the combination of a single-dose local administration of ASP and β-TCP/PLGA had an additive effect on local bone formation in osteoporosis rats, and bone regeneration by PLGA/β-TCP/ASP occured in a dose-dependent manner.
KeywordsOsteoporotic bone defect β-Tricalcium phosphate Poly-lactic-co-glycolic acid Aspirin Regeneration
Compliance with Ethical Standards
Conflict of interest
All authors have no conflicts of interest.
This study did not involve human participants.
This study does not involve human participants and therefore does not require informed consent.
- 1.Boulier A, Schwarz J, Lespesailles E, Baniel A, Tomé D, Blais A (2017) Combination of micellar casein with calcium and vitamins D2 and K2 improves bone status of ovariectomized mice. Osteoporos Int 27:1–10Google Scholar
- 3.Thormann U, Ray S, Sommer U, Elkhassawna T, Rehling T, Hundgeburth M, Henß A, Rohnke M, Janek J, Lips KS, Heiss C, Schlewitz G, Szalay G, Schumacher M, Gelinsky M, Schnettler R, Alt V (2013) Bone formation induced by strontium modified calcium phosphate cement in critical-size metaphyseal fracture defects in ovariectomized rats. Biomaterials 34:8589–8598CrossRefGoogle Scholar
- 14.Tao ZS, Zhou WS, Qiang Z, Tu KK, Huang ZL, Xu HM, Sun T, Lv YX, Cui W, Yang L (2016) Intermittent administration of human parathyroid hormone (1–34) increases fixation of strontium-doped hydroxyapatite coating titanium implants via electrochemical deposition in ovariectomized rat femur. J Biomater Appl 30(7):952–960CrossRefGoogle Scholar
- 15.Tao ZS, Zhou WS, He XW, Liu W, Bai BL, Zhou Q, Huang ZL, Tu KK, Li H, Sun T, Lv YX, Cui W, Yang L (2016) A comparative study of zinc, magnesium, strontium-incorporated hydroxyapatite-coated titanium implants for osseointegration of osteopenic rats. Mater Sci Eng C Mater Biol Appl 62:226–232. https://doi.org/10.1016/j.msec.2016.01.034 CrossRefPubMedGoogle Scholar
- 16.Tao ZS, Zhou WS, Wu XJ, Wang L, Yang M, Xie JB, Xu ZJ, Ding GZ (2019) Single-dose local administration of parathyroid hormone (1–34, PTH) with beta-tricalcium phosphate/collagen (beta-TCP/COL) enhances bone defect healing in ovariectomized rats. J Bone Miner Metab 37:28–35. https://doi.org/10.1007/s00774-018-0906-3 CrossRefPubMedGoogle Scholar
- 18.Kajii F, Iwai A, Tanaka H, Matsui K, Kawai T, Kamakura S (2018) Single-dose local administration of teriparatide with a octacalcium phosphate collagen composite enhances bone regeneration in a rodent critical-sized calvarial defect. J Biomed Mater Res Part B Appl Biomater 106:1851–1857CrossRefGoogle Scholar
- 20.Tao ZS, Zhou WS, Tu KK, Huang ZL, Zhou Q, Sun T, Lv YX, Cui W, Yang L (2015) Effect exerted by teriparatide upon repair function of beta-tricalcium phosphate to ovariectomised rat’s femoral metaphysis defect caused by osteoporosis. Injury 46:2134–2141. https://doi.org/10.1016/j.injury.2015.07.042 CrossRefPubMedGoogle Scholar
- 21.Tao ZS, Zhou WS, Wu XJ, Zhang X, Wang L, Xie JB, Xu ZJ, Ding GZ, Yang M (2019) Prevention of ovariectomy-induced osteoporosis in rats : comparative study of zoledronic acid, parathyroid hormone (1–34) and strontium ranelate. Z Gerontol Geriatr 52:139–147. https://doi.org/10.1007/s00391-018-1376-x CrossRefPubMedGoogle Scholar
- 38.Carbone LD, Tylavsky FA, Cauley JA, Harris TB, Lang TF, Bauer DC, Barrow KD, Kritchevsky SB (2003) Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity. J Bone Miner Res 18:1795–1802. https://doi.org/10.1359/jbmr.2003.18.10.1795 CrossRefPubMedGoogle Scholar
- 39.Xie H, Cui Z, Wang L, Xia Z, Hu Y, Xian L, Li C, Xie L, Crane J, Wan M, Zhen G, Bian Q, Yu B, Chang W, Qiu T, Pickarski M, Duong LT, Windle JJ, Luo X, Liao E, Cao X (2014) PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med 20:1270–1278CrossRefGoogle Scholar
- 40.Kusumbe AP, Ramasamy SK, Adams RH (2014) Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nat Biotechnol 507:323–328Google Scholar